|
| Press Releases |
|
 |
|
| Wednesday, June 10, 2020 |
|
|
Avance Clinical在2020年生物科技創新組織數字會議上表示，TrialTrove數據顯示，澳大利亞開始復工 |
| 澳大利亞領先的生物科技合同研究組織Avance Clinical在今天的生物科技創新組織數字會議上宣布，目前，澳大利亞共有2413個計劃或在行測試項目。在澳大利亞，雖然新冠疫情肆虐，健康志願研究並未中止，只有27個一期或二期研究項目因各種原因暫停（TrialTrove，2020年6月9日）。 more info >> |
|
|
Avance Clinical在2020年生物科技创新组织数字会议上表示，TrialTrove数据显示，澳大利亚开始复工 |
| 澳大利亚领先的生物科技合同研究组织Avance Clinical在今天的生物科技创新组织数字会议上宣布，目前，澳大利亚共有2413个计划或在行测试项目。 more info >> |
|
| Tuesday, June 9, 2020 |
|
|
TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020 |
| The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital today that Australia currently has 2,413 trials planned or ongoing. more info >> |
|
| Monday, April 13, 2020 |
|
|
Australian CRO Avance Clinical Designated an Essential Service as Strong Demand from Sponsors Continues Amid COVID-19 Crisis |
| Leading Australian CRO Avance Clinical said there was still strong demand from Asian and US sponsors, and commended Australian sites that had risen to the challenge to deliver for Avance Clinical clients during this difficult time. more info >> |
|
| Thursday, April 9, 2020 |
|
|
호주 CRO 아방스 클리니컬, COVID-19 위기 속 지속되고 있는 스폰서들의 높은 수요 상황에서 필수 서비스로 지정 |
| 호주의 앞서가는 임상시험수탁기관(CRO)인 아방스 클리니컬(Avance Clinical)은 아시아와 미국 지역 스폰서들의 수요가 여전히 높다고 밝히며, 이 어려운 시국에 도전에 잘 대처하고 있는 호주가 아방스 클리니컬 고객사들의 기대에 부응하고 있다고 칭찬했다. more info >> |
|
|
澳大利亞CRO Avance Clinical指定了一項基本服務，因為在新冠肺炎危機期間，來自讚助商的強烈需求仍在持續 |
| 澳大利亞領先的CRO Avance Clinical表示，亞洲和美國贊助商的需求仍然強勁，並對澳大利亞臨床研究機構在這一困難時期為Avance Clinical客戶提供服務的挑戰表示讚賞。 more info >> |
|
|
澳大利亚CRO Avance Clinical指定了一项基本服务，因为在新冠肺炎危机期间，来自赞助商的强烈需求仍在持续 |
| 澳大利亚领先的CRO Avance Clinical表示，亚洲和美国赞助商的需求仍然强劲，并对澳大利亚临床研究机构在这一困难时期为Avance Clinical客户提供服务的挑战表示赞赏。 more info >> |
|
|
Australian CRO Avance Clinical Designated an Essential Service as Strong Demand from Sponsors Continues Amid COVID-19 Crisis |
| Leading Australian CRO Avance Clinical said there was still strong demand from Asian and US sponsors, and commended Australian sites that had risen to the challenge to deliver for Avance Clinical clients during this difficult time. more info >> |
|
| Friday, April 3, 2020 |
|
|
Avance Clinical 公司的亞太生物科技客戶選擇澳大利亞進行臨床試驗的主要原因 |
| 作為業內翹楚的澳大利亞醫藥研發外包公司—— Avance Clinical公司，今天詳細介紹了其亞太生物技術客戶選擇澳大利亞進行早期臨床試驗的主要原因。 more info >> |
|
|
Avance Clinical 公司的亚太生物科技客户选择澳大利亚进行临床试验的主要原因 |
| 作为业内翘楚的澳大利亚医药研发外包公司—— Avance Clinical公司，今天详细介绍了其亚太生物技术客户选择澳大利亚进行早期临床试验的主要原因。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 23:30: JST
|
|
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 22:30 HKT/SGT
|
|
|
Six Factors to Consider When Opting for a Credit Line in Singapore
May 22, 2026 19:05 HKT/SGT
|
|
|
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
May 22, 2026 18:46: JST
|
|
|
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
May 22, 2026 17:46 HKT/SGT
|
|
|
天辰生物通過聆訊：深耕過敏與自身免疫領域 臨床療效全面領先
May 22, 2026 16:32 HKT/SGT
|
|
|
天辰生物通过聆讯：深耕过敏与自身免疫领域 临床疗效全面领先
May 22, 2026 16:32 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 11:05: JST
|
|
|
雲頂新耀獲主要股東康橋資本增持 全球化佈局有望持續受益
May 22, 2026 10:59 HKT/SGT
|
|
|
GTJAI Won Two Awards at HR Asia 2026
May 22, 2026 10:49 HKT/SGT
|
|
|
國泰君安國際斬獲HR Asia 2026年度兩項大獎
May 22, 2026 10:49 HKT/SGT
|
|
|
国泰君安国际斩获HR Asia 2026年度两项大奖
May 22, 2026 10:49 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 10:05 HKT/SGT
|
|
|
云顶新耀获主要股东康桥资本增持 全球化布局有望持续受益
May 22, 2026 10:05 HKT/SGT
|
|
|
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026
May 22, 2026 0:23 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
